Skip to main content
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. — Investor Relations & Filings

Ticker · DLB ISIN · US25659T1079 LEI · 549300X04FB2QPCJ5J24 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,698 across all filing types
Latest filing 2026-04-30 Interim / Quarterly Rep…
Country US United States of America
Listing US DLB

About Dolby Laboratories, Inc.

https://www.dolby.com/

Dolby Laboratories, Inc. specializes in creating audio, visual, and voice technologies designed to enhance entertainment and communications. Originally known for its audio noise reduction and encoding systems, the company develops and licenses a broad portfolio of technologies. Key offerings include Dolby Atmos for immersive sound and Dolby Vision for high-dynamic-range (HDR) imaging, which have become standards in content creation and playback. These technologies are integrated into a wide array of applications, including cinema, home entertainment, mobile devices, broadcast, music, and gaming, with the goal of transforming the science of sight and sound into more spectacular and immersive experiences for consumers.

Recent filings

Filing Released Lang Actions
10-Q - Dolby Laboratories, Inc. (0001308547) (Filer)
Interim / Quarterly Report
2026-04-30 English
SCHEDULE 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - DOLBY LABORATORIES, INC. (0001308547) (Filer)
Director's Dealing
2026-02-27 English
4 - DOLBY LABORATORIES, INC. (0001308547) (Filer)
Director's Dealing
2026-02-18 English
4 - DOLBY LABORATORIES, INC. (0001308547) (Filer)
Director's Dealing
2026-02-17 English
4 - DOLBY LABORATORIES, INC. (0001308547) (Filer)
Director's Dealing
2026-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.